Principal company Partner company Value ($M) Technologies Date

October

Alder Biopharmaceuticals Inc. H. Lundbeck A/S $1,950.00 Monoclonal antibody humanized; antibody; biological therapeutic; immunoglobulin-G; infusion; intravenous formulation; monoclonal antibody; parenteral formulation unspecified; peptide; protein recombinant; subcutaneous formulation 10/22/19
Beckley Canopy Therapeutics Canopy Growth Corp. Payment unspecified Natural product 10/15/19
Chardan Healthcare Acquisition Corp. Biomx Ltd. Payment unspecified Bacteriophage recombinant (Primary) 10/28/19
Encycle Therapeutics Inc. Zealand Pharma A/S $80.00 Small molecule therapeutic; oral formulation; peptidomimetic 10/22/19
Flodesign Sonics Inc. Merck KGaA Payment unspecified Autologous stem cell therapy 10/10/19
Meitheal Pharmaceuticals Nanjing King-friend Biochemical Pharmaceutical Co. Ltd. $95.00 Generic product 10/31/19
Nestle Skin Health EQT Partners AB $10,346.88 Small molecule therapeutic 10/2/19
Progenics Pharmaceuticals Inc. Lantheus Medical Imaging Inc. Payment unspecified Small molecule therapeutic; non-bioinformatics software deal 10/1/19
Semma Therapeutics Inc. Vertex Pharmaceuticals Inc. $950.00 Stem cell therapy 10/10/19
Smith Therapeutics Inc. Aztherapies Inc. Payment unspecified Chimeric antigen receptor T cell therapy; peptide; receptor chimeric; T-lymphocyte 10/24/19

No Comments